Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

An Update on Innate Immune Responses during SARS-CoV-2 Infection

Zhang, Y. L., Chen, S., Jin, Y., Ji, W., Zhang, W., & Duan, G. (2021) · Viruses · doi:10.3390/v13102060 · Cited by 21

Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action

Ma, Q., Wang, Z., Chen, R., Lei, B., Liu, B., Jiang, H., Chen, Z., Cai, X., Guo, X., Zhou, M., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153874 · Cited by 19

Epigenetic rewiring of pathways related to odour perception in immune cells exposed to SARS-CoV-2in vivoandin vitro

Huoman, J., Sayyab, S., Apostolou, E., Karlsson, L., Porcile, L., Rizwan, M., Sharma, S., Das, J., Rosén, A., & Lerm, M. (2022) · Epigenetics · doi:10.1080/15592294.2022.2089471 · Cited by 19

The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

Jasim, S. A., Mahdi, R. S., Bokov, D. O., Najm, M. A. A., Sobirova, G. N., Bafoeva, Z. O., Taifi, A., Alkadir, O. K. A., Mustafa, Y. F., Mirzaei, R., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28000 · Cited by 21

Current understanding on long non-coding RNAs in immune response to COVID-19

Ding, J., Chen, J., Yin, X., & zhou, J. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198956 · Cited by 19

Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19

Zhang, J., Zhang, Y., Xia, Y., & Sun, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.034 · Cited by 19

Airway Epithelial-Derived Immune Mediators in COVID-19

Guo, T. J. F., Singhera, G. K., Leung, J. M., & Dorscheid, D. R. (2023) · Viruses · doi:10.3390/v15081655 · Cited by 22

Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review

Al‐Ansari, M. M., Sahlah, S. A., AlHumaid, L., & Singh, A. J. R. (2020) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2020.101286 · Cited by 19

Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review

Peddapalli, A., Gehani, M., Kalle, A. M., Peddapalli, S. R., Peter, A. E., & Sharad, S. (2021) · Viruses · doi:10.3390/v13030378 · Cited by 19

Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time

Wirtz, S. J., Schulz-Kuhnt, A., Neurath, M. F., & Atreya, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688879 · Cited by 19

Insights into the Role of Neutrophils and Neutrophil Extracellular Traps in Causing Cardiovascular Complications in Patients with COVID-19: A Systematic Review

Nappi, F., Bellomo, F., & Singh, S. S. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092460 · Cited by 18

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccinePreprint

Furuyama, W., Shifflett, K., Pinski, A. N., Griffin, A. J., Feldmann, F., Okumura, A., Gourdine, T., Jankeel, A., Lovaglio, J., Hanley, P. W., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.19.426885 · Cited by 19

Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis

Ortiz, J. A., Lozano‐Rodríguez, R., Martín‐Quirós, A., Maroun‐Eid, C., Terrón, V., Valentín, J., Montalbán-Hernández, K. M., de la Bastida, F. R., García-Garrido, M. Á., Cubillos‐Zapata, C., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05635 · Cited by 18

An update: the emerging evidence of complement involvement in COVID-19

Li, Q., & Chen, Z. (2021) · Medical Microbiology and Immunology · doi:10.1007/s00430-021-00704-7 · Cited by 18

Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report

Martín‐Quirós, A., Maroun‐Eid, C., Ortiz, J. A., Lozano‐Rodríguez, R., Quiroga, J. V., Terrón, V., Montalbán-Hernández, K. M., García-Garrido, M. Á., del Val, E. M., del Balzo‐Castillo, Á., et al. (2021) · Biomedicine Hub · doi:10.1159/000514727 · Cited by 19

Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection

Chapoval, S. P., & Keegan, A. D. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00423-y · Cited by 18

The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Feng, Y., Tang, K. L., Lai, Q., Liang, J., Feng, M. H., Zhou, Z., Cui, H., Du, X., Zhang, H., & Sun, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.818297 · Cited by 18

Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid

Jiang, Y., Yan, Q., Liu, C., Peng, C.-W., Zheng, W., Zhuang, H., Huang, H.-T., Liu, Q., Liao, H., Zhan, S., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105601 · Cited by 19

Dysregulation of immunity in COVID-19 and SLE

Hejazian, S. S., Hejazian, S. M., Farnood, F., & Azar, S. A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01047-2 · Cited by 20

Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets

Zhao, S., Jiang, M., Qing, H., & Ni, J. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16187 · Cited by 19

Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19?

Saleki, K., Alijanizadeh, P., & Azadmehr, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115558 · Cited by 18

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Vitte, J., Michel, M., Mezouar, S., Diallo, A. B., Boumaza, A. F., Mège, J., & Desnues, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02159 · Cited by 18

A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections

Alamri, A., Fisk, D., Upreti, D., & Kung, S. K. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031118 · Cited by 18

Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M–CSF– and IL-34-differentiated macrophages in vitro

Duarte, C. L., Akkaoui, J., Ho, A., Garcia, C., Yamada, C., & Movilă, A. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.01.104 · Cited by 18

Immune Profiling of COVID-19 in Correlation with SARS and MERS

Khalil, B. A., Shakartalla, S. B., Goel, S., Mdkhana, B., Halwani, R., Maghazachi, A. A., AlSafar, H. S., Al‐Omari, B., & Bataineh, M. T. A. (2022) · Viruses · doi:10.3390/v14010164 · Cited by 18

SARS-CoV-2 Infection: A Possible Risk Factor for Incidence and Recurrence of Cancers

Jafarzadeh, A., Gosain, R., Mortazavi, S. M. J., Nemati, M., Jafarzadeh, S., & Ghaderi, A. A. (2022) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v16i2.9205 · Cited by 19

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

Pérez, R., Glaser, T., Villegas, C., Burgos, V., Ulrich, H., & Paz, C. (2022) · Life · doi:10.3390/life12122117 · Cited by 20

The CCR5-delta32 variant might explain part of the association between COVID-19 and the chemokine-receptor gene clusterPreprint

Gómez, J., Cuesta‐Llavona, E., Albaiceta, G. M., Clemente, M. M. G., López‐Larrea, C., Amado‐Rodríguez, L., López-Alonso, I., Hermida, T., Enríquez-Rodríguez, A. I., Gil, H., et al. (2020) · medRxiv · doi:10.1101/2020.11.02.20224659 · Cited by 18

Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19

Cavaillon, J., Chousterman, B. G., & Skirecki, T. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.01.001 · Cited by 18

Laboratory findings in SARS-CoV-2 infections: State of the art

Pereira, M. A. M., Barros, I. C. D. A., Jacob, A. L. V., de Assis, M. L., Kanaan, S., & Kang, H. C. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.8.1152 · Cited by 17

Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease

Toor, D., Jain, A., Kalhan, S., Manocha, H., Sharma, V. K., Jain, P., Tripathi, V., & Prakash, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.570698 · Cited by 17

Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19

Zhu, Y., Geng, S., Li, Q., & Jiang, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.557652 · Cited by 18

Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys

Coleman, C., Doyle‐Meyers, L. A., Russell‐Lodrigue, K., Golden, N., Threeton, B., Song, K., Pierre, G., Baribault, C., Bohm, R. P., Maness, N. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.754642 · Cited by 17

Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19

Udovičić, I., Stanojević, I., Djordjevic, D., Zeba, S., Rondović, G., Abazovic, T., Lazic, S., Vojvodić, D., To, K., Abazović, D., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245815 · Cited by 19

Identification of serum metabolites enhancing inflammatory responses in COVID-19

Zhang, C., Zhang, B., Li, M., Wei, X., Gong, K., Li, Z., Yao, X., Wu, J., Zhang, C., Zhu, M., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2099-7 · Cited by 15

Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19

Ravichandran, S., Manickam, N., & Kandasamy, M. (2022) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2022.100136 · Cited by 18

Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19

Jin, Q., Li, W., Yu, W., Zeng, M., Liu, J., & Xu, P. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106134 · Cited by 18

IL-33 and the Cytokine Storm in COVID-19: From a Potential Immunological Relationship towards Precision Medicine

Furci, F., Murdaca, G., Allegra, A., Gammeri, L., Senna, G., & Gangemi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314532 · Cited by 17

Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methyl-dependent changes in epigenetic markings

Cassiano, L. M. G., Cavalcante‐Silva, V., Oliveira, M. D. S., Prado, B. V. O., Cardoso, C. G., Salim, A. C. M., Franco, G. R., D’Almeida, V., Francisco, S. C., & Coimbra, R. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1048790 · Cited by 17

Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence

Bolesławska, I., Kowalówka, M., Bolesławska-Król, N., & Przysławski, J. (2023) · Viruses · doi:10.3390/v15061262 · Cited by 18

NSAIDs for early management of acute respiratory infections

Bassetti, M., Andreoni, M., Santus, P., & Scaglione, F. (2024) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001024 · Cited by 18

A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019

Stefano, L. D., Bobbio‐Pallavicini, F., Manzo, A., Montecucco, C., & Bugatti, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572635 · Cited by 17

Molecular biology of coronaviruses: an overview of virus-host interactions and pathogenesis

Hidalgo, P., Alemán, M. V., & González, R. A. (2021) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.20000249 · Cited by 19

COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective

Cavaillon, J.-M., & Osuchowski, M. F. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.04.003 · Cited by 17

Respiratory Nasal Mucosa in Chronic Rhinosinusitis with Nasal Polyps versus COVID-19: Histopathology, Electron Microscopy Analysis and Assessing of Tissue Interleukin-33

Jeican, I. I., Gheban, D., Barbu–Tudoran, L., Inișca, P., Albu, C., Ilieș, M., Albu, S., Vică, M. L., Matei, H. V., Tripon, S. C., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184110 · Cited by 20

Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients

Mangge, H., Prüller, F., Dawczynski, C., Curcic, P., Sloup, Z., Holter, M., Herrmann, M., & Meinitzer, A. (2022) · Antioxidants · doi:10.3390/antiox11071235 · Cited by 17

A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system

Williams, A., Branscome, H., Khatkar, P., Mensah, G. A., Sharif, S. A., Pinto, D. O., DeMarino, C., & Kashanchi, F. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00998-6 · Cited by 16

Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients

Hamldar, S., Kiani, S. J., Khoshmirsafa, M., Nahand, J. S., Mirzaei, H., Khatami, A., Kahyesh‐Esfandiary, R., Khanaliha, K., Tavakoli, A., Babakhaniyan, K., et al. (2022) · Biologicals · doi:10.1016/j.biologicals.2022.09.001 · Cited by 16

Dysregulation of glutamine/glutamate metabolism in COVID‐19 patients: A metabolism study in African population and mini meta‐analysis

Li, X., Tu, B., Zhang, X., Xu, W., Chen, J., Zhao, G., Xu, B., Zheng, J., Yan, Y., Hao, P., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28150 · Cited by 16

Cytokine storm and translating IL-6 biology into effective treatments for COVID-19

Li, T., Wang, D., Wei, H., & Xu, X. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1044-4 · Cited by 16

Cardiovascular manifestations of COVID-19

Altamimi, H., Abid, A., Othman, F., & Patel, A. A. A. H. (2020) · Heart Views · doi:10.4103/heartviews.heartviews_150_20 · Cited by 16

Transcriptomic analysis reveals novel mechanisms of SARS‐CoV‐2 infection in human lung cells

Yang, S., Wu, S., Yu, Z., Huang, J., Zhong, X., Liu, X., Zhu, H., Xiao, L., Deng, Q., & Sun, W. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.366 · Cited by 16

Micronutrients and phytochemicals against COVID-19: Mechanism and molecular targets

Bellik, Y., Bachir‐bey, M., Fatmi, W., Kouidri, M., Souagui, Y., & Selles, S. M. A. (2020) · Annals of Phytomedicine An International Journal · doi:10.21276/ap.2020.9.2.3 · Cited by 15

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses

Cao, Y., Xu, X., Kitanovski, S., Song, L., Wang, J., Hao, P., & Hoffmann, D. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656433 · Cited by 17

The Many Faces of Innate Immunity in SARS-CoV-2 Infection

Hanan, N., Doud, R. L., Park, I.-W., Jones, H. P., & Mathew, S. O. (2021) · Vaccines · doi:10.3390/vaccines9060596 · Cited by 17

Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes

Islam, M. B., Chowdhury, U. N., Nain, Z., Uddin, S., Ahmed, M. B., & Moni, M. A. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104668 · Cited by 15

Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia

Ghanem, M., Homps-Legrand, M., Garnier, M., Morer, L., Goletto, T., Frija‐Masson, J., Wicky, P.-H., Jaquet, P., Bancal, C., Hurtado-Nédelec, M., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00105.2021 · Cited by 17

An autoantigen-ome from HS-Sultan B-Lymphoblasts offers a molecular map for investigating autoimmune sequelae of COVID-19

Wang, J. Y., Zhang, W., Roehrl, V. B., Roehrl, M. W., & Roehrl, M. H. A. (2023) · Australian Journal of Chemistry · doi:10.1071/ch22267 · Cited by 16

Coronavirus Disease (COVID-19): A Perspective from Immunosenescence

Genebat, M., Tarancón‐Díez, L., Pablo-Bernal, R. S. D., Calderón, A., Muñoz‐Fernández, M. Á., & Leal, M. (2021) · Aging and Disease · doi:10.14336/ad.2020.0831 · Cited by 15

Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review

Fan, Y., Wang, Y., Yu, S., Chang, J. B. P., Yan, Y., Wang, Y., & Bian, Y. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00478-3 · Cited by 15

IL-17A in COVID-19 Cases: a meta-analysis

Fadlallah, S. M., Eddin, M. S., & Rahal, E. A. (2021) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.15285 · Cited by 15

Chronic alcohol consumption dysregulates innate immune response to SARS-CoV-2 in the lung

Lewis, S. A., Cinco, I. R., Doratt, B. M., Blanton, M. B., Hoagland, C., Newman, N., Davies, M., Grant, K. A., & Messaoudi, I. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104812 · Cited by 15

Molecular Aspects of Co-morbidities in COVID-19 Infection.

Pouya, F., Saber, Z. I., & Kerachian, M. A. (2020) · PubMed Central · doi:10.22038/abjs.2020.47828.2361 · Cited by 15

SARS-CoV-2 virus and other epidemic coronaviruses: pathogenetic and genetic factors for the development of infections

Болдырева, М. Н. (2020) · Immunologiya · doi:10.33029/0206-4952-2020-41-3-197-205 · Cited by 17

C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19

Adesanya, T. M. A., Campbell, C. M., Cheng, L., Ogbogu, P. U., & Kahwash, R. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-00972-1 · Cited by 15

Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient’s lung cells

George, B., Revikumar, A., Paul, A. M., Santhoshkumar, T. R., Pillai, M. R., & Kumar, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-87703-z · Cited by 15

A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseases

Scott, T. M., Jensen, S., & Pickett, B. E. (2021) · F1000Research · doi:10.12688/f1000research.52412.1 · Cited by 13

Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation

Castle, R., Williams, M. A., Bushell, W. C., Rindfleisch, J. A., Peterson, C. T., Marzolf, J. R., Brouwer, K. C., & Mills, P. J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s323356 · Cited by 15

COVID-19 and Long-Term Outcomes: Lessons from Other Critical Care Illnesses and Potential Mechanisms

Arbov, E., Tayara, A., Wu, S., Rich, T. C., & Wagener, B. M. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0374ps · Cited by 15

The putative mechanism of lymphopenia in COVID-19 patients

Wang, X., Liu, Z., Lu, L., & Jiang, S. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac034 · Cited by 15

Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19

Abbas, A. A., Alghamdi, A., Mezghani, S., Ayed, M. B., Alamori, A. M., Alghamdi, G. A., Bajhmom, W., Wajeeh, H., Almutairi, S. S., & Radwan, W. M. (2022) · Journal of Immunology Research · doi:10.1155/2022/6336556 · Cited by 15

False negative SARS-CoV-2 PCR - A case report and literature review

Wiseman, J., D'Amico, T. A., Zawadzka, S., & Anyimadu, H. (2020) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2020.101140 · Cited by 14

Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2

Singh, D. D., Han, I., Choi, E. H., & Yadav, D. K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.011 · Cited by 14

Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods

Li, X., Zhou, X., Ding, S., Chen, L., Feng, K., Li, H., Huang, T., & Cai, Y. (2022) · Biomolecules · doi:10.3390/biom12121735 · Cited by 17

Cardiovascular Disease in Post-Acute COVID-19 Syndrome: A Comprehensive Review of Pathophysiology and Diagnosis Approach

Kusumawardhani, N. Y., Putra, I. C. S., Kamarullah, W., Afrianti, R., Pramudyo, M., Iqbal, M., Prameswari, H. S., Achmad, C., Tiksnadi, B. B., & Akbar, M. R. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2401028 · Cited by 16

Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53

Lee, J. D., Menasché, B. L., Mavrikaki, M., Uyemura, M. M., Hong, S. M., Kozlova, N. V., Wei, J., Alfajaro, M. M., Filler, R. B., Müller, A. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113478 · Cited by 17

THE PREDICTED STRUCTURE FOR THE ANTI-SENSE SIRNA OF THE RNA POLYMERASE ENZYME (RDRP) GENE OF THE SARS-COV-2

Parikesit, A. A., & Nurdiansyah, R. (2020) · BERITA BIOLOGI · doi:10.14203/beritabiologi.v19i1.3849 · Cited by 14

Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges

Hajivalili, M., Hosseini, M. S., & Haji-Fatahaliha, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118058 · Cited by 15

SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes

Sirpilla, O. L., Bauss, J. M., Gupta, R., Underwood, A. C., Qutob, D., Freeland, T., Bupp, C. P., Carcillo, J. A., Hartog, N., Rajasekaran, S., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00421 · Cited by 14

The COVID-19 Pandemic: an Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia

Govender, R., Moodley, J., & Naicker, T. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01126-9 · Cited by 16

T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications

Sarmiento-Monroy, J. C., Parra-Medina, R. S., Garavito, É., & Rojas‐Villarraga, A. (2021) · Viral Immunology · doi:10.1089/vim.2020.0177 · Cited by 13

Uremia-Associated Immunological Aging and Severity of COVID-19 Infection

Betjes, M. G. H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.675573 · Cited by 15

Role of the Immune Microenvironment in SARS-CoV-2 Infection

Ye, C.-H., Hsu, W., Peng, G.-R., Yu, W.-C., Lin, W., Hu, S., & Yu, S. (2021) · Cell Transplantation · doi:10.1177/09636897211010632 · Cited by 15

A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19

Zhu, Z., Zhang, S., Wang, P., Chen, X., Bi, J., Cheng, L., & Zhang, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab446 · Cited by 14

Transcriptomic Profiles Reveal Downregulation of Low-Density Lipoprotein Particle Receptor Pathway Activity in Patients Surviving Severe COVID-19

Vlasov, I. N., Panteleeva, A., Usenko, T. S., Nikolaev, M. A., Izyumchenko, A. D., Gavrilova, E., Shlyk, I. V., Мирошникова, В. В., Shadrina, M. I., Polushin, Y. S., et al. (2021) · Cells · doi:10.3390/cells10123495 · Cited by 14

Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19

Kocherlakota, C., Banda, N., Narala, A., Srinath, A., Kothapalli, K. S. D., & Brenna, J. T. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102426 · Cited by 16

Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection

Zeng, Q., Qi, X., Ma, J., Hu, F., Wang, X., Qin, H., Li, M., Huang, S., Yang, Y., Li, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104309 · Cited by 14

Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C

Dhaliwal, M., Tyagi, R., Malhotra, P., Barman, P., Loganathan, S. K., Sharma, J., Sharma, K., Mondal, S., Rawat, A. K., & Singh, S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.790273 · Cited by 15

Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2

Gallo, V., Arienzo, A., Iacobelli, S., Iacobelli, V., & Antonini, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137314 · Cited by 16

Nonproductive exposure of PBMCs to SARS‐CoV‐2 induces cell‐intrinsic innate immune responses

Kazmierski, J., Friedmann, K., Postmus, D., Emanuel, J., Fischer, C., Jansen, J., Richter, A. M., de Jarcy, L. B., Schüler, C., Sohn, M., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210961 · Cited by 15

Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients

Krygier, A., Szmajda‐Krygier, D., Świechowski, R., Pietrzak, J., Wosiak, A., Wodziński, D., & Balcerczak, E. (2022) · Biomolecules · doi:10.3390/biom12121845 · Cited by 15

The kidney, COVID-19, and the chemokine network: an intriguing trio

Taverna, G., Francesco, S. D., Borroni, E. M., Yiu, D., Toniato, E., Milanesi, S., Chiriva‐Internati, M., Bresalier, R. S., Zanoni, M. L., Vota, P., et al. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02579-8 · Cited by 14

The relationship between human coronaviruses, asthma and allergy—An unresolved dilemma

Chałubiński, M., Gajewski, A., & Kowalski, M. L. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13718 · Cited by 14

Repurposing of thalidomide and its derivatives for the treatment of SARS‐coV‐2 infections: Hints on molecular action

Sundaresan, L., Giri, S., Singh, H., & Chatterjee, S. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14792 · Cited by 14

Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19

Yang, Y. K., Huang, W., Fan, Y., & Chen, G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.647508 · Cited by 15

Targeting TGF-β pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19Preprint

Trieu, V. N., Saund, S., Rahate, P. V., Barge, V. B., Nalk, K. S., Windlass, H., & Uckun, F. M. (2021) · medRxiv · doi:10.1101/2021.01.24.21250418 · Cited by 14

Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID

Narayanan, J., Tamilanban, T., Senthilkumar, P., Guru, A., Saravanan, M., Kathiravan, M. K., & Arockiaraj, J. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03559-z · Cited by 15

Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets

Wang, L., Koelink, P. J., Garssen, J., Folkerts, G., Henricks, P. A. J., & Braber, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074058 · Cited by 13

The Covid-19, Epidemiology, Clinic and Prevention

Antonelli, A., Elia, G., Ferrari, S. M., Foddis, R., Marco, S. D., Cristaudo, A., & Fallahi, P. (2020) · Current Genomics · doi:10.2174/1389202921999200427133052 · Cited by 13

An Integrative Analysis Identifying Transcriptional Features and key Genes Involved in COVID-19

Li, G., Wang, J., He, X., Zhang, L., Qin, R., Xiong, A., Wu, D., Hu, L., Song, Q., & Zhu, D. M. (2020) · Epigenomics · doi:10.2217/epi-2020-0168 · Cited by 13

Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection

Cavalli, E., Petralia, M. C., Basile, M. S., Bramanti, A., Bramanti, P., Nicoletti, F., Spandidos, D. A., Shoenfeld, Y., & Fagone, P. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4702 · Cited by 37

Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsPreprint

de Melo, C. V. B., Bhuiyan, M. A., Gatua, W., Kanyerezi, S., Uzairue, L. I., Abechi, P., Kumar, K., Rahmat, J., Giwa, A. O., Mwandira, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.289850 · Cited by 2

Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers

Abdallah, A. M., Ansari, H., Shuaib, M., Doudin, A., Yassine, H. M., Shah, S. S. U. D., Mir, F., Emara, M., Elzouki, A.-N., & Cyprian, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-04837-0 · Cited by 1

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Zhou, Z. L., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.017 · Cited by 980

Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse

Gardinassi, L. G., Souza, C. O. S., Sales‐Campos, H., & Fonseca, S. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01636 · Cited by 112